2A2554: DEXTROSE AND ELECTROLYTE INJECTI.
DEXTROSE AND ELECTROLYTE INJECTI. Key specifications include primary_container_type: BOTTLE WITH HANGING DEVICE, GLASS, pharmaceutical_vehicle_type: AQUEOUS, primary_container_content_quantity: 1000.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-201-8167, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | BOTTLE WITH HANGING DEVICE, GLASS |
| pharmaceutical_vehicle_type | AQUEOUS |
| total_primary_container_quantity | 6 |
| primary_container_content_quantity | 1000.000 MILLILITERS |
| NSN | 6505-01-201-8167 |
| PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | BOTTLE WITH HANGING DEVICE, GLASS |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIEQUIVALENTS CALCIUM ION ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS CHLORIDE ION ACTIVE INGREDIENT AND 7.000 MILLIEQUIVALENTS SODIUM ION ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 47.00 MILLIEQUIVALENTS ACETATE PER LITER AND 8.50 MILLIEQUIVALENTS LACTATE PER LITER AND 3.00 MILLIEQUIVALENTS MAGNESIUM PER LITER AND 10.00 MILLIEQUIVALENTS POTASSIUM PER LITER |
| TOTAL PRIMARY CONTAINER QUANTITY | 6 |
No substitute or cross-reference records for this part.